Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publicación Otros (Other)

Aging Affects Pancreatic α-Cell Function and Promotes Hyperglucagonemia: Implications in Age-Associated Diabetes

  • Tudurí, Eva|||/items/ed03c763-6d0f-4b5a-a720-80238ac8cc4e
  • Almagro, Lucía
  • Ojeda-Rodríguez, Ana
  • Pascua-Maestro, Raquel
  • Brunetta, Henver S.
  • Soriano, Sergi|||/items/8e3d590c-5b30-415a-93aa-bf5d4506efe4
  • López-Moreno, Alejandro
  • Boronat-Belda, Talía
  • Velasco-Avilés, Sergio
  • da Silva Junior, Joel Alves
  • Castellano-Muñoz, Manuel
  • Rafacho, Alex
  • Cozar-Castellano, Irene
  • Nadal, Ángel
  • Alonso Magdalena, Paloma
  • Merino, Beatriz
  • Lopez-Miranda, Jose
  • Quesada, Iván
Aging is a major risk factor in the development of type 2 diabetes mellitus (T2DM). With age, pancreatic β-cells undergo functional and cell identity changes that can compromise insulin secretion, thereby contributing to impaired glucose tolerance and T2DM. However, glucose homeostasis also depends on pancreatic α-cells. Excessive plasma glucagon levels, along with impaired regulation of α-cell secretion, are involved in the pathophysiology of T2DM. Despite their importance, the effects of aging on α-cells have been overlooked. In the present study, we analyzed pancreatic α-cells in aged mice with normal insulin sensitivity and in those with peripheral insulin resistance. Regardless of insulin sensitivity, aged mice exhibited hyperglucagonemia and increased glucagon release. Ex vivo, these alterations were associated with increased α-cell mass, higher glucagon content, impaired suppression of glucagon secretion, and endoplasmic reticulum stress. Furthermore, aged mice showed remodeling of islet cellular composition and changes in the spatial organization of α-cells within the islet. Additionally, moderate alterations in α-cell identity were noted. While most of these alterations were already present in aged mice with normal insulin sensitivity, they were generally more pronounced with insulin resistance. Examination of the CORDIOPREV clinical study revealed the presence of hyperglucagonemia in older adults with insulin resistance. Additionally, an increased risk of developing T2DM was also found in older people with higher plasma glucagon levels. The findings described here indicate that aging affects the biology of α-cells and glucagon, positioning them as active players in impaired glucose tolerance and diabetes associated with aging.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Lipoprotein particle profile in the presence of peripheral artery disease among patients with coronary heart disease: Data from the CORDIOPREV study

  • Cruz Ares, Silvia de la
  • Coronado Carvajal, P.
  • Rangel Zúñiga, Oriol Alberto
  • Torres‑Peña, J.D.
  • Arenas de Larriva, Antonio P.
  • López-Moreno, Alejandro
  • Katsiki, Niki
  • Ordovás, José M.
  • Delgado-Lista, Javier
  • Pérez-Martínez, Pablo
  • Gutiérrez-Mariscal, Francisco M.
  • López-Miranda, José
BACKGROUND: Dyslipidemia is recognized as a contributing factor to peripheral artery disease (PAD). However, the influence of lipoprotein subfractions as compared to traditional serum lipid lev- els is not well-understood. Objective: This study explores the association between lipoprotein subfractions and the occurrence of PAD in patients with coronary heart disease (CHD). METHODS: In the CORDIOPREV study, 981 patients were categorized based on PAD diagnosis, determined by an ankle-brachial index (ABI) ≤0.9. Those with ABI >0.9 and <1.4 were consid- ered PAD-free, while patients with ABI ≥1.4 were excluded. We employed high-throughput nuclear magnetic resonance (NMR) spectroscopy to analyze the concentration and lipid content of lipoprotein subfractions. RESULTS: PAD patients exhibited significantly lower levels of medium high-density lipoprotein (HDL) particles and reduced concentrations of associated lipids within these subfractions except for triglycerides. A higher concentration of large or medium HDL particles correlated with a lower PAD prevalence (odds ratio [OR]: 0.61, 95% CI, 0.44-0.84; OR: 0.59, 95% CI, 0.43-0.81, respectively). In multivariate logistic regression, medium HDL particle levels inversely associated with PAD presence (OR: 0.69, 95% CI, 0.48–0.99, P = .044) after adjustment for confounding factors. CONCLUSIONS: The presence of PAD among CHD patients inversely correlates with medium HDL particle concentrations as determined by NMR. These insights could advance our understanding of PAD pathophysiology and HDL metabolism.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Dietary antioxidant intake reduces carotid intima-media thickness in coronary heart disease patients: From the CORDIOPREV study

  • Rivas García, Lorenzo
  • Quintana-Navarro, Gracia M.
  • Torres‑Peña, J.D.
  • Arenas de Larriva, Antonio P.
  • Alcalá Díaz, Juan Francisco
  • Yubero-Serrano, Elena M.
  • Pérez-Caballero, Ana I.
  • Ortiz Morales, Ana María
  • Rangel Zúñiga, Oriol Alberto
  • López-Moreno, Alejandro
  • Ordovás, José María
  • Pérez-Martínez, Pablo
  • López-Miranda, José
  • Delgado-Lista, Javier
Background: Atherosclerosis is the leading underlying cause of coronary heart disease (CHD). In patients with CHD, intima-media thickness of common carotid arteries (IMT-CC) is a reliable, validated, and non-invasive marker of the progression of atherosclerosis. Dietary intervention may affect IMT-CC evolution through different pathways. There is a lack of clinical trials evaluating the effect of total dietary antioxidant content of diets on IMT-CC, especially in patients with CHD. Objective: We evaluated the correlation between the diet's total antioxidant content and the changes in IMT-CC produced after 5 years of dietary intervention following two healthy diet models (Mediterranean diet and low-fat diet). We also evaluated whether the diet's total antioxidant content was related to the total redox capacity of the participants. Methods: From the total participants of the CORDIOPREV study (clinical trial register NCT00924937), 805 participants completed the IMT-CC measurement and the dietary antioxidant evaluation at baseline and after 5 years of dietary intervention. IMT-CC was carried out by ultrasound and the dietary antioxidant evaluation was performed by the Dietary Antioxidant Index (DAI). Additionally, direct redox balance was evaluated in a subset of population by the ratio of reduced glutathione (GSH) to oxidized glutathione (GSSH) by colorimetric assay. Results We observed an inverse correlation between evolution of DAI and IMT-CC after 5-years of dietary intervention. The mean of the DAI index augmented in the Mediterranean Diet group, whereas it decreased in the Low-fat group. DAI was correlated to the GSH/GSSG ratio, supporting DAI as an adequate estimator of diet's antioxidant content. When looking for individual components of the DAI that were associated to the changes in IMT-CC, an inverse correlation was found for carotenoids, vitamin E, vitamin C, and zinc and the IMT-CC. Conclusions: Our study indicates that, after five years of dietary intervention, changes in DAI inversely correlate with changes in IMT-CC in patients with CHD. Overall effect of Mediterranean diet resulted in an increase of DAI, conversely to low-fat. Specific elements included in the DAI index were inversely correlated with IMT-CC.
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Risk of short telomere as biomarker of diabetes mellitus type 2 status in the CORDIOPREV study, Riesgo de telómero corto como biomarcador de diabetes mellitus tipo 2 en el estudio CORDIOPREV

  • Ojeda-Rodríguez, Ana
  • Párraga-Viudez, María José
  • Romero-Cabrera, Juan Luis
  • López-Moreno, Alejandro
  • Arenas-Montes, Javier
  • Pérez-Caballero, Ana I.
  • Luque, Raúl M.
  • Delgado-Lista, Javier
  • Rangel-Zuñiga, Oriol Alberto
  • López-Miranda, José
Embargado hasta 19/12/2026, Background The presence of type 2 diabetes mellitus (T2DM) in cardiovascular disease (CVD) is associated with poorer clinical outcomes. To identify biomarkers is essential to predict T2DM onset and progression in the context of secondary prevention. Telomere length (TL), a marker of cellular aging, has been linked to oxidative stress, inflammation, and metabolic dysfunction, including diabetes-related complications. This study aims to evaluate TL as a potential biomarker for T2DM in patients with coronary heart disease (CHD). Methods We included 956 patients from the CORDIOPREV study with available TL data. Participants were classified according to their diabetes status at the end of the dietary intervention: 407 were free of T2DM and 549 were classified as having T2DM. TL was measured by quantitative PCR. Patients with TL values below the 20th percentile of the study population were categorized as having short telomeres. Results TL was significantly shorter in T2DM patients compared to non-T2DM (1.26 ± 0.74 vs. 1.38 ± 0.84; p = 0.026). Each 1-SD increase in TL was associated with a 17% lower risk of T2DM (OR 0.83, 95% CI 0.69–0.98). Patients at risk of short TL (<20th percentile) showed a higher prevalence of T2DM (20% vs. 17%; p = 0.035) and a 42% increased risk of its presence (OR 1.42, 95% CI 0.99–2.02). In stepwise regression models, TL, age, BMI, insulin, triglycerides, and HbA1c emerged as independent predictors of T2DM. After adjusting for fasting glucose, TL lost significance as a continuous variable, but short TL risk remained independently associated with T2DM (OR 1.57, p = 0.049). Conclusions Shorter TL is associated with the presence of T2DM in patients with CHD, supporting its potential role as an independent biomarker for T2DM risk in secondary prevention., Resumen Antecedentes La presencia de diabetes mellitus tipo 2 (DMT2) en la enfermedad cardiovascular se asocia con peores resultados clínicos. Identificar biomarcadores es esencial para predecir la aparición y progresión de la DMT2 en el contexto de la prevención secundaria. La longitud de los telómeros (LT), un marcador de envejecimiento celular se ha relacionado con el estrés oxidativo, la inflamación y la disfunción metabólica, incluidas las complicaciones asociadas a la diabetes. Este estudio tiene como objetivo evaluar la LT como un biomarcador potencial de la DMT2 en pacientes con enfermedad coronaria (EC). Métodos Se incluyeron 956 pacientes del estudio CORDIOPREV con datos disponibles de LT. Los participantes fueron clasificados según su estado diabético al final de la intervención dietética: 407 estaban libres de DMT2 y 549 fueron clasificados con DMT2. La LT se midió mediante PCR cuantitativa. Los pacientes con valores de LT por debajo del percentil 20 de la población del estudio fueron categorizados como en riesgo de telómeros cortos. Resultados La LT fue significativamente más corta en los pacientes con DMT2 en comparación con los no diabéticos (1,26 ± 0,74 vs. 1,38 ± 0,84; p = 0,026). Cada incremento de 1 DE en LT se asoció con un 17% menos de riesgo de DMT2 (OR 0,83; IC 95%: 0,69–0,98). Los pacientes en riesgo de LT corta (< percentil 20) mostraron una mayor prevalencia de DMT2 (20% vs. 17%; p = 0,035) y un aumento del 42% en el riesgo de su presencia (OR 1,42; IC 95%: 0,99–2,02). En los modelos de regresión por pasos, la LT, la edad, el IMC, la insulina, los triglicéridos y la HbA1c emergieron como predictores independientes de la DMT2. Tras ajustar por glucosa en ayunas, la LT perdió significancia como variable continua, pero el riesgo de LT corta permaneció asociado de manera independiente con la DMT2 (OR 1,57; p = 0,049). Conclusiones Una LT más corta se asocia con la presencia de DMT2 en pacientes con EC, lo que respalda su potencial papel como biomarcador independiente de riesgo de DMT2 en prevención secundaria.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial

  • Gutiérrez-Mariscal, Francisco Miguel
  • López-Moreno, Alejandro
  • Torres-Peña, José D.
  • Gómez-Luna, Purificación
  • Arenas-de Larriva, Antonio P.
  • Romero-Cabrera, Juan Luis
  • Luque, Raúl M.
  • Uribarri, Jaime
  • Pérez-Martínez, Pablo
  • Delgado-Lista, Javier
  • Yubero-Serrano, Elena María
  • López-Miranda, José
16 Páginas.-- 5 Figuras.-- 2 Tablas, Background: Increasing evidence supports the role of advanced glycation end products (AGEs) in atherosclerosis in both diabetic and non-diabetic patients, suggesting that therapeutic strategies targeting AGEs may offer potential benefits in this population. The Mediterranean diet is associated with improved biomarkers and anthropometric measurements related with atherosclerosis in addition to its ability to modulate AGE metabolism. Our aim was to determine whether the reduction in atherosclerosis progression (measured by changes in intima-media thickness of both common carotid arteries (IMT-CC)), observed after consumption of a Mediterranean diet compared to a low-fat diet, is associated with a modulation of circulating AGE levels in patients with coronary heart disease (CHD). Methods: 1002 CHD patients were divided in: (1) Non-increased IMT-CC patients, whose IMT-CC was reduced or not changed after dietary intervention and (2) Increased IMT-CC patients, whose IMT-CC was increased after dietary intervention. Serum AGE levels (methylglyoxal–MG and Nε-Carboxymethyllysine-CML) and parameters related to AGE metabolism (AGER1 and GloxI mRNA and sRAGE levels) and reduced glutathione (GSH) levels were measured before and after 5-years of dietary intervention. Results: The Mediterranean diet did not affect MG levels, whereas the low-fat diet significantly increased them compared to baseline (p = 0.029), leading to lower MG levels following the Mediterranean diet than the low-fat diet (p < 0.001). The Mediterranean diet, but not the low-fat diet, produced an upregulation of AGE metabolism, with increased AGER1 and GloxI gene expression as well as increased GSH and sRAGE levels in Non-increased IMT-CC patients (all p < 0.05). Although the Mediterranean diet increased MG levels in Increased IMT-CC patients, this increment was lower compared to the low-fat diet (all p < 0.05). Conclusions: Our results suggest that an improvement in modulation of AGE metabolism, which facilitates better management of circulating AGE levels, may be one of the mechanisms through which the Mediterranean diet, compared to a low-fat diet, reduces the progression of atherosclerosis in patients with CHD. Trial registration https://clinicaltrials.gov/ct2/show/NCT00924937, Clinicaltrials.gov number, NCT00924937. Graphical abstract: (Figure presented.)., The CORDIOPREV study was supported by the Fundación Patrimonio Comunal Olivarero(Cordioprev-CEAS, 1/2016 to Jose Lopez-Miranda). This study also received research grants from Ministerio de Ciencia e Innovación (AGL2012-39615, AGL2015-67896-P and PID2019-104362RB-I00funded by MCIN/AEI/1.0.13039/501100011033 to Jose Lopez-Miranda), from Consejería de Salud-Junta de Andalucía (PC-0283-2017 to Elena M. Yubero-Serrano) and FIS (PI18/01822 and PI21/00383 toElena M Yubero-Serrano), funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. Elena M Yubero-Serrano was the recipient of the Nicolas Monardes Programme from the“Servicio Andaluz de Salud, Junta de Andalucia”, Spain (C1-0005-2019). Francisco M Gutierrez-Mariscal is supported by a CIBEROBN postdoctoral research contract. The funding bodies had no role in thestudy design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut Microbiota Interacts with Dietary Habits in Screenings for Early Detection of Colorectal Cancer

  • Vega-Rojas, Ana
  • Haro, Carmen
  • Molina-Abril, Helena
  • Guil-Luna, Silvia
  • Santos‐Marcos, José A.
  • Gutierrez-Mariscal, Francisco Miguel
  • Garcia-Fernandez, Helena
  • Caballero-Villarraso, Javier
  • Rodriguez-Ariza, Antonio
  • López-Miranda, José
  • Pérez-Martínez, Pablo
  • Hervas, Antonio
  • Camargo, Antonio
[Background/Objectives] Gut microbiota interacts with nutrients, which may be relevant to assigning a microbial signature to colorectal cancer (CRC). We aim to evaluate the potential of gut microbiota combined with dietary habits in the early detection of pathological findings related to CRC in the course of a screening program., [Methodology] The colonoscopy performed on 152 subjects positive for fecal occult blood test showed that 6 subjects had adenocarcinoma, 123 had polyps, and 23 subjects had no pathological findings. Gut microbiota was analyzed by 16S metagenomic. Caret package was used to build the classification models in R., [Results] Random forest (RF) classifier models were used to test the potential of gut microbiota alone or combined with dietary habits as a biomarker to discern between individuals with CRC-related lesions (polyps or adenocarcinoma) versus individuals without pathological findings. RF classifier models yielded an area under the curve of 0.790 using gut microbiota data, 0.710 using dietary habits data, and 0.804 in the combined model including gut microbiota and dietary habits data. The abundance of Suterella, Oscillospirales, Proteobacteria, and Burkholderiales was highly discriminant between groups, together with the consumption of fruit and vegetables and the consumption of carbonated and/or sweetened beverages., [Conclusions] Our results suggest that the interaction between gut microbiota and dietary habits is relevant when a microbial signature is used as a marker in CRC. Moreover, gut microbiota signature and information about the dietary habits of the individuals seem to be important for improving screening programs for the early detection of CRC., This research was funded by the Consejeria de Salud, Junta de Andalucía (PIN-0156-2016 to C.H.); by the Consejeria de Salud y Familias, Junta de Andalucía (PI-0055-2021 to A.C.); by the Ministerio de Ciencia e Innovacion, Spain, through the grants AGL2015-67896-P to J.L.-M. and A.C.; grant PID2019-104362RB funded by MCIN/AEI/10.13039/501100011033; by the ISCIII, Spain, grants CP14/00114, PI19/00299, DTS19/00007, and PI22/00925 to A.C.; and co-funded by the European Union. Antonio Camargo is supported by an ISCIII research contract (Programa Miguel-Servet CP14/00114 and CPII19/00007) and by Servicio Andaluz de Salud-Junta de Andalucia (Nicolas Monardes Programme Contract C1-0001-2022) funding., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Differences in splicing factors may predict type 2 diabetes remission in the CORDIOPREV study

  • Ojeda-Rodríguez, Ana
  • Torres-Peña, José D.
  • Arenas de Larriva, Antonio Pablo
  • Rangel-Zúñiga, Oriol Alberto
  • Podadera-Herreros, Alicia
  • Boughanem, Hatim
  • García, Miguel E. G.
  • López-Moreno, Alejandro
  • Katsiki, Niki
  • Luque, Raúl M.
  • Pérez-Martínez, Pablo
  • Delgado-Lista, Javier
  • Yubero-Serrano, Elena María
  • López-Miranda, José
12 Páginas.-- 4 Figuras, Alternative splicing is a post-transcriptional process resulting in multiple protein isoforms from a single gene. Abnormal splicing may lead to metabolic diseases, including type 2 diabetes mellitus (T2DM). To identify the splicing factor expression that predicts T2DM remission in coronary heart disease (CHD) patients, we identified newly diagnosed T2DM at baseline (n = 190) from the CORDIOPREV study. Patients were classified as Responders (T2DM remission during 5 years without antidiabetic drugs) or non-Responders. Baseline dysregulation in 5 splicing factors (MBNL1, RBM5, hnRNP G/RBMX, CD44, NT5E) distinguished Responders from non-Responders. Adding these factors to clinical variables [AUC = 0.67], insulin resistance, and beta-cell indexes [AUC = 0.76], improved T2DM remission prediction [AUC = 0.80]. Cox regression analysis showed those with higher remission scores had a 2.63-fold increased remission probability. To conclude, a set of splicing factors that contribute to predicting T2DM remission in patients with CHD has been identified. Further research is needed to elucidate these findings' clinical relevance., The CORDIOPREV study is supported by the Fundación Patrimonio Comunal Olivarero (Cordioprev-CEAS, 1/2016 to J.L.-M.). The main sponsor was not involved in the design or carrying out the study, and its participation was limited to funding and providing the olive oil used in the study. This study also received research grants from Ministerio de Ciencia e Innovación (AGL2012-39615, AGL2015-67896-P and PID2019-104362RB-I00 funded by MCIN/AEI/1.0.13039/501100011033 to J.L.-M.), from Consejería de Salud-Junta de Andalucía (PC-0283-2017 to E.M.Y.-S.) and FIS (PI18/01822 and PI21/00383 to E.M.Y.-S.), integrated into the framework of the National Plan for Scientific Research, Technological Development and Innovation 2013–2016, co-financed by the Instituto de Salud Carlos III (ISCIII) of Spain and also by the Directorate General for Assessment and Promotion of Research and the EU’s European Regional Development Fund (FEDER). A.O.-R. and H.B. were the recipients of Sara Borrell grants (CD21/00099 and CD22/00053, respectively) from the ISCIII. The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank the EASP (Escuela Andaluza de Salud Publica), Granada (Spain), for carrying out the randomization process in this study. The CIBEROBN is an initiative of the Instituto de Salud Carlos III, Madrid, Spain. The authors declare no competing interests. The authors read and approved the final manuscript., Peer reviewed